Feb 08, 2024 / 01:00PM GMT
Operator
Greetings and welcome to the MET Axis third fiscal quarter 2024 conference call. (Operator Instructions) Please note this conference is being recorded. I will now turn the conference over to your host, Victoria Rutherford, investor relations, Victoria you may begin.
Victoria Rutherford - Medexus Pharmaceuticals Inc - IR Contact Officer
Thank you and good morning, everyone, and welcome to the Dexus Pharmaceuticals third fiscal quarter 2021 earnings call. On the call this morning are Ken dâEntremont, our Chief Executive Officer; and Marcel Konrad, Chief Financial Officer. If you have any questions after the conference call or would like further information about the company, please contact Adelaide capital at four eight zero six two five five seven seven two. I would like to remind everyone that this discussion will include forward-looking information as defined in securities laws.
Actual results may differ materially from historical results or results anticipated by the forward-looking information. In addition, some discussion will also include non-GAAP
Q3 2024 Medexus Pharmaceuticals Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot